发明名称 Use of L-2-oxothiazolidine-4-carboxylate alone or in combination with glutathione esters and/or amino acids in the treatment of reperfusion injury.
摘要 <p>The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a composition for treating and/or reducing ischemic reperfusion injury. To this end, in embodiment, the composition is used for treating and/or reducing reperfusion injury in a patient in danger of reperfusion injury. In an embodiment, the composition is used for limiting an expected ischemic reperfusion injury in a patient prior to an expected ischemic event. In a further embodiment of the present invention, the composition is used for limiting ischemic reperfusion injury in a patient after the onset of an ischemic event.</p>
申请公布号 EP0501637(A2) 申请公布日期 1992.09.02
申请号 EP19920301226 申请日期 1992.02.14
申请人 CLINTEC NUTRITION COMPANY 发明人 GOLDBERG, DENNIS I.;MADSEN, DAVID C.;ROWE, BRUCE W.
分类号 A61K31/095;A61K31/22;A61K31/425;A61K38/00;A61K45/00;A61P9/00;A61P9/10 主分类号 A61K31/095
代理机构 代理人
主权项
地址